ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
0.90
0.00
( 0.00% )
Updated: 03:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.90
Bid
0.85
Ask
0.95
Volume
0.00
0.90 Day's Range 0.90
0.825 52 Week Range 3.75
Market Cap
Previous Close
0.90
Open
0.90
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
277,601
Shares Outstanding
413,204,037
Dividend Yield
-
PE Ratio
-1.13
Earnings Per Share (EPS)
-0.02
Revenue
195k
Net Profit
-7.31M

About Future Metals Nl

Sector
Miscellaneous Metal Ores,nec
Industry
Miscellaneous Metal Ores,nec
Headquarters
Perth, Western Australia, Aus
Founded
-
Future Metals Nl is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker FME. The last closing price for Future Metals Nl was 0.90p. Over the last year, Future Metals Nl shares have traded in a share price range of 0.825p to 3.75p.

Future Metals Nl currently has 413,204,037 shares outstanding. The market capitalization of Future Metals Nl is £3.72 million. Future Metals Nl has a price to earnings ratio (PE ratio) of -1.13.

FME Latest News

Future Metals NL Heritage Surveys Completed & Testing Eileen Bore

Future Metals NL 16 September 2024   Future Metals NL Heritage Surveys Completed to Allow Drill Testing of Eileen Bore Mineralisation Highlights: ·        Heritage clearance surveys completed...

TRADING UPDATES: Hellenic Dynamics loan delay; Argent's Sintef tie-up

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

Future Metals NL Results of the Option Offer and Shortfall

Future Metals NL 21 August 2024     21 August 2024 Future Metals NL Results of the Option Offer and Shortfall   Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME) is pleased...

Future Metals NL Company Update

Future Metals NL 09 August 2024   Company Update Continued Reduction in Corporate Expenditure   Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME), advises that, in line with...

Future Metals NL Option Offer

Future Metals NL 31 July 2024   31 July 2024 Future Metals NL Option Offer   Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME), is pleased to announce, further to its...

Future Metals NL Quarterly Activities Report

Future Metals NL 29 July 2024     29 July 2024 Future Metals NL Quarterly Activities Report for quarter ended 31 June 2024 Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME...

Future Metals NL Change of Auditor & Issue of Underwriter Options

Future Metals NL 04 July 2024   4 July 2024 Future Metals NL   Change of Auditor & Issue of Underwriter Options Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME...

Future Metals NL Grant of Director Performance Rights

Future Metals NL 03 July 2024   3 July 2024 Future Metals NL   Grant of Director Performance Rights Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME) announces that it has...

Future Metals NL Issue of Equity and Change of Registered Office

Future Metals NL 02 July 2024   2 July 2024 Future Metals NL Issue of Equity Change of Registered Office Address   Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME) announces...

Future Metals NL Results of General Meeting

Future Metals NL 25 June 2024   25 June 2024 Future Metals NL Results of General Meeting Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME) is pleased to announce, in...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.90.90.9819090.9DE
40.0252.857142857140.8750.9250.875563650.8995898DE
12-0.1-1011.2250.8252776010.97212068DE
26-0.7-43.751.61.60.8252364521.10338778DE
52-1.45-61.70212765962.353.750.8256516181.81815753DE
156-10.35-9211.2514.50.8254964532.85705865DE
260-10.35-9211.2514.50.8254964532.85705865DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CLCOCloudcoco Group Plc
0.155p
(72.22%)
10M
OBIOndine Biomedical Inc.
6.875p
(22.22%)
692.12k
FABFusion Antibodies Plc
3.90p
(20.00%)
2.16M
ALFAlternative Liquidity Fund Limited
$ 0.045
(20.00%)
11.43k
ITIMItim Group Plc
41.50p
(18.57%)
65.71k
AC8Acceler8 Ventures Plc
90.00p
(-43.75%)
1.58k
CRCLCorcel Plc
0.1025p
(-21.15%)
23.41M
FLKFletcher King Plc
39.50p
(-21.00%)
21.86k
TM1Technology Minerals Plc
0.10p
(-20.00%)
11.94M
CARDCard Factory Plc
116.20p
(-18.74%)
9.82M
CLONClontarf Energy Plc
0.0505p
(-12.17%)
563.92M
NTVONativo Resources Plc
0.0025p
(-3.85%)
428.57M
MSMNMosman Oil And Gas Limited
0.035p
(-2.78%)
260.93M
GBPGlobal Petroleum Limited
0.14p
(-6.67%)
186.53M
MOSMobile Streams Plc
0.1825p
(1.39%)
116.12M

Discussion

View Full Feed
MADDSTACKER MADDSTACKER 3 minutes ago
Great news :)
VFF
PRCubaDog PRCubaDog 3 minutes ago
This is pumper boys way of saying he lied and hasn't bought a share in years. 🤣🤣🤣 BK IMMINENT!
INNDD
fuagf fuagf 3 minutes ago
You're right, two good posts by you questioning OMOLIVE's position, the first here ..

I don't understand what you are trying to prove.

2) Gradual increase in the age of eligibility for full benefits to age 66 in 2009 and to age 67 in 2027. The earnings test will also b
jackson73 jackson73 3 minutes ago
SEEL .41 ww on news out
RIGATONI RIGATONI 3 minutes ago
$6.68 with a new high on news...


Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

https://finance.yahoo.com/news/capricor-therapeutics-ann
CAPR
JohnSmith4 JohnSmith4 3 minutes ago
BAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHHAHAHAHAHAHAHAHAHAHHAHA
TSOI
subslover subslover 4 minutes ago
I told that dog over 1 month ago to call a plumber. He got upset with at that statement so Roto-Rooter never showed
MLGO
2020trader 2020trader 4 minutes ago
this truly a garbage stock
CLNV
DGJR DGJR 4 minutes ago
Where does it show how many shares he sold and or transferred to others, show the proof.
AABB
Volcano Volcano 4 minutes ago
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today, following recent meetings with the U.S. Food and Drug Administration (FDA), its intent to file a Biologics License Applicat
CAPR
mascale mascale 5 minutes ago
The actual "Gold Standard" in electrical conductors is Copper.
HIRU
bigstocksnbonds bigstocksnbonds 5 minutes ago
Oct 25 is great!!

Congrats on ALL!!!!!!!
cottonmather cottonmather 5 minutes ago
Langley Outdoors. Polls suggest a Trump win. 11 minutes https://www.youtube.com/watch?v=rt85n0Zfmts
TheKid5 TheKid5 5 minutes ago
No funding. WV is dead. 1 year wasted. the future is bright
CLNV
toogoodfella toogoodfella 5 minutes ago
RE:.. The distribution of about 1M or more maybe the final.

—//——-//—-

CORRECTION: “100M or more”
LEHNQ
2020trader 2020trader 5 minutes ago
expecting lower today
SINC
Mufaso Mufaso 5 minutes ago
One thing I need to correct is that the allegation Toexane is making about stocking. The SEC filing says

...including breaches of the maximum levels of buffer stock...

The normal stocking problem you have with a distributor is that they don't have enough. In this
RVNC
jay_tee jay_tee 5 minutes ago
Go retake PUMP 101
RNVA
2020trader 2020trader 6 minutes ago
guaranteed
SINC
carolinatiger carolinatiger 6 minutes ago
As I continue to say. But yet, you are here. Everyone knows why.
IGPK
TheKid5 TheKid5 6 minutes ago
Great call! The future is bright! Funding any day now.
CLNV
RIGATONI RIGATONI 6 minutes ago
First news in a long time...

Do the dd while its still down here

https://x.com/rigatoni33/status/1838551947172860017
Volcano Volcano 6 minutes ago
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today, following recent meetings with the U.S. Food and Drug Administration (FDA), its intent to file a Biologics License Applicat
CAPR
nagoya1 nagoya1 7 minutes ago
Without being cheeky, I stuck that K suppository where it belongs.
FNMA
FNMA
MartinLutherKing MartinLutherKing 7 minutes ago
Last call ALL aboard FOXO NYSE Spaceship AI medical revelation
FOXO

Your Recent History

Delayed Upgrade Clock